Johns Hopkins Cancer Center

Baltimore, Maryland 21287

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Anaplastic Astrocytoma, Chronic Myelomonocytic Leukemia, Glioblastoma Multiforme, IDH1 Mutation Myeloid Neoplasms, Non-Small-Cell Lung Cancer

Studies at this site

• IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation — Completed
• IDH2 Inhibition Using Enasidenib as Maintenance Therapy for IDH2-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation — Completed
• Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2 — Stopped early
• Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer — Completed